U.S. Markets closed

FluoroPharma Medical, Inc. (FPMI)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.045+0.01 (+12.50%)
At close: 1:42PM EDT
People also watch
BTHEANTBGOVXGTHPSNWV
Interactive chart
Previous Close0.040
Open0.040
Bid0.000 x
Ask0.000 x
Day's Range0.040 - 0.045
52 Week Range0.030 - 0.290
Volume25,265
Avg. Volume33,250
Market Cap1.54M
Beta1.04
PE Ratio (TTM)-0.58
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube2 years ago

    FluoroPharma Medical, Inc. Earnings Q2, 2015

    FluoroPharma Medical, Inc. reports preliminary financial results for the quarter ended June 30, 2015.We analyze the earnings along side the following peers of FluoroPharma Medical, Inc. – Studsvik AB Unsponsored ADR and PharmAthene, Inc. (SUDKY-US and PIP-US) that have also reported for this period.HighlightsThe table below shows the preliminary results and recent trends for key (Read more...) The post FluoroPharma Medical, Inc. Earnings Q2, 2015 appeared first on CapitalCube.

  • Zacks Small Cap Research2 years ago

    FPMI: 2014 Results, Maintaining Buy Recommendation

    We are maintaining our Buy recommendation.  See below for free access to our updated report on FPMI. Authors of the article, titled A New F-18 Labeled PET Tracer For Fatty Acid Imaging, note that initial data from the study has shown CardioPET can better identify differences in fatty acid uptake as compared to the comparator, that is Tc-99m-SPECT, in the evaluation of CAD.  Specifically, in a patient with CAD that underwent a stress test, CardioPET identified differences in fatty acid (FA) uptake in areas where Tc-99m-SPECT showed no abnormalities.  As fatty acid uptake will decrease with acute or chronic myocardial ischemia, accurately identifying decreased uptake is important in diagnosing the full extent of coronary stenosis (i.e.

  • Zacks Small Cap Research3 years ago

    FPMI: CardioPET Data A Catalyst to Share Price Appreciation

    By Brian Marckx, CFA OTC:FPMI We have updated our report on FluoroPharma Medical (OTC:FPMI).  See below for free access to our full report on the company.    Development of FluoroPharma's CardioPET nuclear ...